Skip to Main Content

Paper Details

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
EClinicalMedicine
12
2023
1490, B, B/, B/F, Bictegravir, CD4+, DTG, HDL, HIV, HIV-1, HIV-1 RNA, TAF, abacavir, cholesterol, dolutegravir, emtricitabine, lamivudine, participants, people, tenofovir alafenamide
Author NameAffiliation
Paul E SaxBrigham and Women's Hospital and Harvard Medical School
Jos?? R ArribasHospital Universitario La Paz
Edwin DeJesus
Hans-Jürgen StellbrinkUniversity of Hamburg
David A WohlUniversity of North Carolina School of Medicine
  • 1 - 5

Datasets

Release 1.2